Results 221 to 230 of about 4,769,368 (347)

Microsatellite-high intrahepatic cholangiocarcinoma with favorable treatment outcome using pembrolizumab. [PDF]

Clin J Gastroenterol
Horiguchi S, Kato H, Miyamoto K, Morimoto K, Matsumi A, Terasawa H, Fujii Y, Matsumoto K, Tanaka T, Otsuka M.   +9 more
europepmc   +1 more source

Symptomatic and functional outcome of surgical treatment of cervical dystonia [PDF]

, 1997
Joachim K. Krauss, Elizabeth G. Toups, Joseph Jankovic, Robert G. Grossman   +3 more
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Predictors of tuberculosis treatment outcome at Senkatana clinic in Lesotho. [PDF]

Pan Afr Med J
Kabuya RM, Musekiwa A, Takuva S, Thabane L, Mbuagbaw L.   +4 more
europepmc   +1 more source

Treatment Outcome of Alcoholics with and without Cocaine Disorders [PDF]

, 1994
Kirk J. Brower, Frederic C. Blow, Elizabeth M. Hill, Sharon A. Mudd   +3 more
openalex  

Alcoholism treatment outcome studies, 1980–1992: The nature of the research

, 1996
Anthony S. Floyd, Susanne C. Monahan, John W. Finney, Jeanne A. Morley   +3 more
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Neurosurgical Outcomes in a Modern Series of 400 Craniotomies for Treatment of Parenchymal Tumors

, 1998
Ronald E. Warnick, John M. Tew
openalex   +1 more source

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil [PDF]

, 1999
M C Etienne, Xavier Pivot, Jean–Louis Formento, René‐Jean Bensadoun, Patricia Formento, O. Dassonville, M Francoual, G. Poissonnet, Xavier Fontana, M. Schneider, F Démard, G. Milano   +11 more
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source